Celldex Therapeutics, Inc., a biopharmaceutical company, develops, manufactures, and commercializes novel therapeutics for human health care in the United States. The company’s lead drug candidates comprise rindopepimut (CDX-110), a targeted immunotherapeutic in a pivotal Phase III study for the treatment of front-line glioblastoma, as well as in Phase II study for the treatment of recurrent glioblastoma; and Glembatumumab vedotin (CDX-011), a targeted antibody-drug conjugate in a randomized Phase IIb study for the treatment of triple negative breast cancer, as well as in Phase II study for the treatment of metastatic melanoma.
Take a look at the 1-year chart of Celldex (NASDAQ: CLDX) below with my added notations:
After its big gap lower back in August, CLDX started to trade somewhat sideways over the following 5 months. During that stretch, the stock had a tendency of creating support and resistance levels at the increments of $2 (purple). Even now the most recent level of resistance was at $8 (red), and the most recent support has been $6 earlier in the month.
Join our new Linkedin Group by clicking the link below:
The Tale of the Tape: CLDX tends to react to each $2 level. A long trade could be made on a beak through $8, or on a pullback to $6, with a stop placed under the level of entry. A short trade could be made on a break below $6, or on a rally to $8.
Before making any trading decision, decide which side of the trade you believe gives you the highest probability of success. Do you prefer the short side of the market, long side, or do you want to be in the market at all? If you haven’t thought about it, review the overall indices themselves. For example, take a look at the S&P 500. Is it trending higher or lower? Has it recently broken through a key resistance or support level? Making these decisions ahead of time will help you decide which side of the trade you believe gives you the best opportunities.
No matter what your strategy or when you decide to enter, always remember to use protective stops and you’ll be around for the next trade. Capital preservation is always key!
Christian Tharp, CMT
Follow me on Twitter: @cmtstockcoach